- Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group. Kaufmann, R., Spieth, K., Leiter, U., Mauch, C., von den Driesch, P., Vogt, T., Linse, R., Tilgen, W., Schadendorf, D., Becker, J.C., Sebastian, G., Krengel, S., Kretschmer, L., Garbe, C., Dummer, R. J. Clin. Oncol. (2005)